Inicio539523 • BOM
add
Alkem Laboratories Ltd
Cierre anterior
4723,95 ₹
Intervalo diario
4609,50 ₹ - 4752,90 ₹
Intervalo anual
4409,90 ₹ - 6440,00 ₹
Cap. bursátil
553,45 mil M INR
Volumen medio
3,59 mil
Relación precio-beneficio
25,73
Rentabilidad por dividendo
0,91 %
Bolsa de valores principal
NSE
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(INR) | dic 2024info | Cambio interanual |
---|---|---|
Ingresos | 33,74 mil M | 1,52 % |
Gastos operativos | 14,96 mil M | 8,29 % |
Ingresos netos | 6258,20 M | 5,19 % |
Margen de beneficio neto | 18,55 | 3,63 % |
Beneficios por acción | 52,34 | -2,59 % |
EBITDA | 7389,20 M | 4,74 % |
Tipo impositivo efectivo | 12,35 % | — |
Balance general
Activos totales
Responsabilidades totales
(INR) | dic 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 22,89 mil M | -36,59 % |
Activos totales | — | — |
Responsabilidades totales | — | — |
Patrimonio total | 119,10 mil M | — |
Acciones en circulación | 119,57 M | — |
Precio-valor contable | 4,91 | — |
Rentabilidad económica | — | — |
Retorno sobre capital | 12,59 % | — |
Flujo de caja
Variación neta del flujo de caja
(INR) | dic 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 6258,20 M | 5,19 % |
Efectivo de operaciones | — | — |
Efectivo de inversión | — | — |
Efectivo de financiación | — | — |
Variación neta del flujo de caja | — | — |
Flujo de caja libre | — | — |
Información sobre la empresa
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Fundación
1973
Sitio web
Empleados
17.432